Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
Clinical trial NCT03339661 · COMPLETED
Trial details
- NCT number
- NCT03339661
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2020-11-23
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.